Technology | Radiation Dose Management | August 19, 2015

Corindus, Unfors Raysafe Partner to Promote Radiation Protection in the Cath Lab

Joint agreement bundles RaySafe i2 real-time radiation dose monitoring system with Corindus’ CorPath vascular robotic system

Corindus, Corpath, radiation dose monitoring, cath lab, vascular robotic system

The Corindus Corpath vascular robotic system.

Unfors RaySafe, RaySafe i2, real-time radiation dose monitoring system

Unfors Raysafe's i2 real-time dose monitoring badge system


August 19, 2015 – Corindus Vascular Robotics Inc. and Unfors RaySafe Inc., a Fluke Biomedical Company, announced a distribution agreement allowing Corindus to offer the RaySafe i2 real-time radiation dose monitoring system in conjunction with the CorPath System. This alignment enables catheterization lab physicians and staff to better protect themselves from, and monitor for, excessive radiation exposure.

The interventional cardiology field is increasingly concerned about the cumulative effects of radiation exposure on physicians and cath lab staff as more studies emerge and stories of individuals who have been forced to leave practice become more prevalent. Top of FormBottom of FormThe The 95 percent radiation exposure reduction afforded by the CorPath System’s radiation shielded cockpit increases protection for interventional cardiologists, while the RaySafe i2 badge worn by cath lab workers displays radiation exposure levels in real-time; this allows the team to be more aware of exposure levels and take steps to minimize exposure, while continuing to deliver a high standard of care.

Spectrum Health System, based in Grand Rapids, Michigan, is one of the first facilities in the United States to install and jointly utilize the CorPath System and RaySafe i2. “We take significant measures to protect our patients, and through the addition of these products, we can do the same for our physicians and cath lab staff,” stated Ryan Madder, M.D., interventional cardiologist at Spectrum Health. “Having integrated the products into my daily practice, I am more aware of both my own exposure levels and that of my team. I appreciate how these technologies can significantly change our behaviors and put us in a safer position to perform procedures.”

For more information: www.corindus.com, www.raysafe.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now